Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
June 15, 2021 | Startland News Staff
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.
“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.
Elevator pitch: Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.
Jim West, Clara Biotech
“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.
Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.
Dr. Mei He, Clara Biotech
Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.
The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.
Click here to read Clara Biotech’s full snapshot update.
“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”
Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.
Click here to learn more about Clara Biotech and how its technology works.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity.
For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.
2021 Startups to Watch
stats here
Related Posts on Startland News
‘Younger eyes’ at Street Wearhouse see opportunity to win through the screen as digital personality meets quality printing
The owners of a recently-opened print studio hope to make an imprint on the industry by taking a different approach to garment design and production, they said. Street Wearhouse, co-founded by Alex Trinkle and Tyler Love, specializes in printing and embroidering T-shirts, hats, and other apparel from its North Kansas City production facility. Trinkle, who…
One of KC’s hottest smashburgers is at this all-natural wine bar; how Big Mood uncorked its potential with popup food, live music
Kansas City’s first all natural wine shop has evolved into more than simply a place to buy wine, said Richard Garcia; Big Mood Natural Wines now is the go-to spot for food, drinks, live entertainment and community. “Big Mood has morphed organically over the past few years into what it is now. When we first…
MVP in his field: Royals groundskeeper earns his own bobblehead for keeping The K green amid ups and downs
For the club’s first-ever Ag Night, the Kansas City Royals are celebrating — and bestowing the honor of a bobblehead — on their very own farmer. That’s what Trevor Vance — who has been keeping the field at Kauffman Stadium perfectly manicured for nearly 40 years — considers himself and other groundskeepers, he shared. “We’re…
Right to Start plans GOP debate on entrepreneurship; If America is going to be saved, Heartland innovators will be key, says leader
A nonprofit founded by a former Kauffman Foundation executive is planning a first-of-its-kind forum on entrepreneurship with four Republican presidential candidates this Friday in the Midwest. Right to Start is a nonpartisan organization that champions entrepreneurship as a civic priority through grassroots organizing and policy advocacy, with the goal of expanding entrepreneurial opportunity. Friday’s forum…